Efficacy of Topotecan and Lapatinib in Early Recurrent Ovarian or Peritoneal Cancer
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objective of the trial was to evaluate the efficacy of the association of topotecan and
lapatinib in patients who failed first line platinum-based chemotherapy within 12 months.
Phase:
Phase 2
Details
Lead Sponsor:
Centre Francois Baclesse
Collaborators:
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète Centre d’Etudes et de Recherche pour l’Intensification du Traitement du Diabète GlaxoSmithKline